Similar articles

• Pharmacokinetics and anti-inflammatory pharmacodynamics of prednisolone in cynomolgus monkey.

  Zheng YJ, Hawk M, Yuan H, Hope HR, Baratta M, Zutshi A. Zheng YJ, et al. Xenobiotica. 2009 Nov;39(11):862-70. doi: 10.3109/00498250903189454. Xenobiotica. 2009. PMID: 19845437
• Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.

  Lebrun-Vignes B, Archer VC, Diquet B, Levron JC, Chosidow O, Puech AJ, Warot D. Lebrun-Vignes B, et al. Br J Clin Pharmacol. 2001 May;51(5):443-50. doi: 10.1046/j.1365-2125.2001.01372.x. Br J Clin Pharmacol. 2001. PMID: 11422002 Free PMC article. Clinical Trial.
• Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.

  Möllmann H, Hochhaus G, Rohatagi S, Barth J, Derendorf H. Möllmann H, et al. Pharm Res. 1995 Jul;12(7):1096-100. doi: 10.1023/a:1016287104656. Pharm Res. 1995. PMID: 7494809 Clinical Trial.
• Pharmacokinetics of corticosteroids during pregnancy.

  Pacheco LD, Ghulmiyyah LM, Snodgrass WR, Hankins GD. Pacheco LD, et al. Am J Perinatol. 2007 Feb;24(2):79-82. doi: 10.1055/s-2006-958162. Epub 2007 Jan 29. Am J Perinatol. 2007. PMID: 17260328 Review.
• Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids.

  Jusko WJ. Jusko WJ. Toxicology. 1995 Sep 1;102(1-2):189-96. doi: 10.1016/0300-483x(95)03047-j. Toxicology. 1995. PMID: 7482553 Review.